Back to list

The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: Results from the A1chieve observational study

Philip D. Home, Zafar A. Latif, Guillermo González-Gálvez, Vinay Prusty and Zanariah Hussein

Diabetes Research and Clinical Practice, 3, 101, pages 326 - 332

Received 3 January 2013, Revised 15 May 2013, Accepted 6 June 2013, Published online Oct-2013


Article view:

Authors

Philip D. Home a lowast , Zafar A. Latif b, Guillermo González-Gálvez c, Vinay Prusty d and Zanariah Hussein e

Footnotes

a Newcastle University, Newcastle upon Tyne, UK

b BIRDEM Hospital, Dhaka, Bangladesh

c Instituto Jalisciense de Investigación en Diabetes y Obesidad, SC, Guadalajara, Jalisco, Mexico

d Novo Nordisk A/S International Operations, Zürich, Switzerland

e Hospital Putrajaya, Putrajaya, Malaysia

lowast Corresponding author. ICM-Diabetes, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, United Kingdom. Tel.: +44 191 222 7154.

This study was funded by Novo Nordisk.

☆☆ Clinical trial registration: Clinicaltrials.gov, NCT00869908.


Back to list